 |
|
Home | Foundation Medicine (FMI) – Investment Analysts’ Weekly Ratings Updates |
 |
Foundation Medicine (FMI) – Investment Analysts’ Weekly Ratings Updates
|
 |
- May 22, 2015
-
Foundation Medicine (NYSE: FMI) has recently received a number of price target changes and ratings updates: 5/14/2015 – Foundation Medicine was downgraded by analysts at Zacks from a “buy” rating to a “hold” rating. Zacks’ analyst wrote, “Foundation Medicine, Inc. provides molecular information products primarily in the United States. The company offers FoundationOne(TM) a molecular […]This article (Foundation Medicine (FMI) – Investment Analysts’ Weekly Ratings Updates) was originally developed by and is property of American Banking News.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
- Read more at:http://www.americanbankingnews.com/2015/05/21/foundation-medicine-fmi-investment-analysts-weekly-ratings-updates/
|
 |
|
 |
|
 |
